Abbott Laboratories
DE ˙ XTRA ˙ US0028241000
75,22 € ↑1,20 (1,62%)
2026-06-03
AKTIENPREIS
SecurityDE:ABL / Abbott Laboratories
InstitutionGarde Capital, Inc.
Latest Disclosed Ownership2,315 shares
Latest Disclosed Value $ 237,683
Garde Capital, Inc. reports 41.33% increase in ownership of ABL / Abbott Laboratories

On April 29, 2026 - Garde Capital, Inc. filed a 13F-HR form disclosing ownership of 2,315 shares of Abbott Laboratories (DE:ABL) valued at $205,618 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 1,638 shares of Abbott Laboratories. This represents a change in shares of 41.33% during the quarter. The current value of the position is $174,134 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-29 2026-03-31 13F ABBOTT LABORATORIES COM 002824100 2,315 677 41.33 238 15.61 0.0142
2026-02-10 2025-12-31 13F ABBOTT LABS COM 002824100 1,638 0 0.00 205 -6.39 0.0122
2025-12-16 2025-09-30 13F ABBOTT LABS COM 002824100 1,638 65 4.13 219 2.82 0.0107
2025-07-03 2025-06-30 13F ABBOTT LABS COM 002824100 1,573 50 3.28 214 5.45 0.0112
2025-04-22 2025-03-31 13F ABBOTT LABS COM 002824100 1,523 -17 -1.10 202 0.0114
2025-02-25 2024-12-31 13F Abbott Laboratories Equities 002824100 1,540 375 32.19 0 0.0115
2024-12-03 2024-09-30 13F Abbott Laboratories Equities 002824100 1,165 -389 -25.03 0 0.0087
2024-08-19 2024-06-30 13F Abbott Laboratories Equities 002824100 1,554 0 0.00 0 0.0112
2024-05-29 2024-03-31 13F Abbott Laboratories Equities 002824100 1,554 -304 -16.36 0 0.0123
2024-02-21 2023-12-31 13F Abbott Laboratories Equities 002824100 1,858 262 16.42 0 0.0156
2023-11-17 2023-09-30 13F Abbott Laboratories Equities 002824100 1,596 25 1.59 0 0.0132
2023-08-29 2023-06-30 13F Abbott Laboratories Equities 002824100 1,571 -89 -5.36 0 0.0142
2023-05-25 2023-03-31 13F Abbott Laboratories Equities 002824100 1,660 -126 -7.05 0 -100.00 0.0184
2023-02-24 2022-12-31 13F Abbott Laboratories Equities 002824100 1,786 160 9.84 196 24.84 0.0235
2022-12-01 2022-09-30 13F JP Morgan Chase Equities 002824100 1,626 0 0.00 157 -11.30 0.0203
2022-08-23 2022-06-30 13F Abbott Laboratories Equities 002824100 1,626 -580 -26.29 177 -32.18 0.0215
2022-05-27 2022-03-31 13F Abbott Laboratories Equities 002824100 2,206 0 0.00 261 -16.08 0.0268
2022-02-25 2021-12-31 13F Abbott Laboratories Equities 002824100 2,206 148 7.19 311 27.98 0.0304
2021-11-17 2021-09-30 13F Abbott Laboratories Equities 002824100 2,058 529 34.60 243 37.29 0.0251
2021-08-19 2021-06-30 13F Abbott Laboratories Equities 002824100 1,529 1 0.07 177 -3.28 0.0183
2021-05-24 2021-03-31 13F Abbott Laboratories Equities 002824100 1,528 201 15.15 183 26.21 0.0212
2021-02-26 2020-12-31 13F Abbott Laboratories Equities 002824100 1,327 1,327 145 0.0177
2019-05-08 2019-03-31 13F ABBOTT LABS COM 002824100 0 -9,375 -100.00 0 -100.00
2019-02-20 2018-12-31 13F ABBOTT LABS COM 002824100 9,375 0 0.00 678 2.26 0.1201
2018-11-16 2018-09-30 13F ABBOTT LABS COM 002824100 9,375 0 0.00 663 15.91 0.1115
2018-08-20 2018-06-30 13F ABBOTT LABS COM 002824100 9,375 75 0.81 572 2.69 0.0990
2018-05-16 2018-03-31 13F ABBOTT LABS COM 002824100 9,300 -150 -1.59 557 3.34 0.1012
2018-02-22 2017-12-31 13F ABBOTT LABS COM Stock 002824100 9,450 -1,395 -12.86 539 -6.91 0.1016
2017-11-17 2017-09-30 13F ABBOTT LABS COM Stock 002824100 10,845 10,845 579 0.1136
2017-02-28 2016-12-31 13F ABBOTT LABS COM Stock 002824100 0 -9,300 -100.00 0 -100.00
2016-11-17 2016-09-30 13F ABBOTT LABS COM Stock 002824100 9,300 9,300 0.00 374 0.1195
2016-05-16 2016-03-31 13F ABBOTT LABS COM Stock 002824100 0 0 0 0.0000
2016-02-08 2015-12-31 13F ABBOTT LABS COM Stock 002824100 0 -9,300 -100.00 0 -100.00
2015-11-17 2015-09-30 13F ABBOTT LABS COM Stock 002824100 9,300 0 0.00 374 -17.98 0.1195
2015-08-04 2015-06-30 13F ABBOTT LABS COM Stock 002824100 9,300 0 0.00 456 5.80 0.1370
2015-04-13 2015-03-31 13F ABBOTT LABS COM Stock 002824100 9,300 0 0.00 431 2.86 0.1306
2015-02-23 2014-12-31 13F ABBOTT LABORATORIES Stock 002824100 9,300 9,300 419 0.1287
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.